Wordt geladen...
18F PET with florbetapir for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)
BACKGROUND: (18)F‐florbetapir uptake by brain tissue measured by positron emission tomography (PET) is accepted by regulatory agencies like the Food and Drug Administration (FDA) and the European Medicine Agencies (EMA) for assessing amyloid load in people with dementia. Its added value is mainly de...
Bewaard in:
| Gepubliceerd in: | Cochrane Database Syst Rev |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley & Sons, Ltd
2017
|
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6486090/ https://ncbi.nlm.nih.gov/pubmed/29164603 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012216.pub2 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|